Amy Legg

Amy Legg is a Research Fellow at the UQ Centre for Clinical Research within the Faculty of Health, Medicine and Behavioural Sciences at The University of Queensland. Holding a Doctor of Philosophy of Health from Charles Darwin University, she is actively engaged in antimicrobial research and is available for student supervision.

Her research focuses on critical areas of infectious disease management including antimicrobial resistance surveillance, antibiotic pharmacokinetics, and nephrotoxicity prevention. Key interests encompass:

• Optimization of beta-lactam and vancomycin dosing
• Staphylococcus aureus bacteraemia treatment protocols
• Penicillin allergy de-labeling programs
• Therapeutic drug monitoring in critical care
• Antimicrobial stewardship initiatives

Recent publication trends reveal strong emphasis on clinical implementation of antibiotic resistance solutions, with significant contributions to Australian national guidelines including the National Antibiotic Allergy Network and AUS-SCAR registry. Her work bridges laboratory research with practical hospital protocols, particularly in nephrotoxicity assessment and antimicrobial dosing optimization.

As part of the UQ Centre for Clinical Research, Legg collaborates extensively with clinical teams across Queensland Health services, contributing to both observational studies and interventional trials like the ROAD Study and PROSPECTOR studies. Her research directly informs clinical practice through publications in journals such as Australian Prescriber and Clinical Infectious Diseases.